I think the large insider buying a few days ago is a sign that potential partners are very interested in Bisantrene . A good licensing deal would let this brutally underpriced und undiscovered stock explode like a nuclear bomb .GLTA
Race Oncology secures services agreement to pursue Bisantrene cancer drug licensing
https://*********.com.au/race-oncology-agreement-pursue-bisantrene-cancer-drug-licensing/
Mcap $6.7 M / Big EFFECTIVE Cancer Drug in P3 (MKT Size ~$500M+) =20+BAGGER, page-4
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.040(2.30%) |
Mkt cap ! $306.5M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.83 | $1.73 | $188.9K | 105.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 2146 | 2 |
View Market Depth
| Last trade - 13.06pm 09/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |